RT Journal Article
SR Electronic
T1 Genetic evidence for causal relationships between age at natural menopause and the risk of aging-associated adverse health outcomes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.26.22269835
DO 10.1101/2022.01.26.22269835
A1 Joanna Lankester
A1 Jin Li
A1 Elias Levy Itshak Salfati
A1 Marcia L. Stefanick
A1 Kei Hang Katie Chan
A1 Simin Liu
A1 Carolyn J. Crandall
A1 Shoa L. Clarke
A1 Themistocles L. Assimes
YR 2022
UL http://medrxiv.org/content/early/2022/07/04/2022.01.26.22269835.abstract
AB Background A later age at natural menopause (ANM) has been linked to several aging-associated traits including an increased risk of breast and endometrial cancer and a decreased risk of lung cancer, osteoporosis, and Alzheimer disease. However, ANM is also related to several proxies for overall health that may confound these associations.Methods We investigated the causal association of ANM with these clinical outcomes using Mendelian randomization (MR). Participants and outcomes analyzed were restricted to post-menopausal females. We conducted a one-sample MR analysis in both the Women’s Health Initiative (WHI) and the UK Biobank (UKB). We further analyzed and integrated several additional datasets of post-menopausal women using a two-sample MR design. We used up to 55 genetic variants previously discovered to be associated with ANM as our instrumental variable.Results A five year increase in ANM was causally associated with a decreased risk of osteoporosis (OR=0.80 [0.70, 0.92]) and fractures (OR=0.76 [0.62, 0.94]) as well as an increased risk of lung cancer (OR=1.35 [1.06, 1.71]). Other associations including atherosclerosis related outcomes were null.Conclusions Our study confirms that the decline in bone density with menopause causally translates to fracture and osteoporosis. Additionally, this is the first causal epidemiologic analysis to our knowledge to find an increased risk of lung cancer with ANM. This finding is consistent with molecular and epidemiologic studies suggesting estrogen dependent growth of lung tumors. Randomized controlled trials of anti-estrogen therapies in the prevention or treatment of lung cancer should be considered if additional MR studies are confirmatory.Key MessagesAs in prior literature, the age of natural menopause (ANM) was observationally associated with increased risk of breast cancer, endometrial cancer, and ovarian cancer, and with a decreased risk of lung cancer, coronary heart disease, ischemic stroke, fracture, osteoporosis, and Alzheimer disease in the Women’s Health Initiative and UK Biobank.However, these associations may be confounded by overall markers of health, such as smoking, so we used a genetic instrument variable to look at the causality of ANM on these adverse outcomes using Mendelian randomization.A five year increase in ANM was causally associated with decreased risk of fracture and osteoporosis, but with an increase lung cancer.This increase in ANM was not significantly associated with other outcomes; notably, there was no causal association of ANM with coronary heart disease or ischemic stroke.Given the increase in lung cancer risk and prior molecular studies linking lung cancer to estrogen receptor expression, randomized controlled trials of anti-estrogen therapies for prevention or treatment of lung cancer should be considered, should these results be replicated in additional studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJoanna Lankester was supported by the National Heart, Lung, and Blood Institute through grant number 5F32HL149254-02 and by the Big Data Scientific Training Enhancement Program (BD-STEP) fellowship program through the Palo Alto Veteran's Affairs.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data sets used in this study are publicly available to researchers by creating an account for the relevant data sources and following posted instructions for obtaining access. Primary data from Women's Health Initiative used for this analysis are available through dbGap and the WHI website: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000746.v3.p3 https://www.whi.org Phenotypic WHI data alone are available through BioLINCC: https://biolincc.nhlbi.nih.gov/home/ Data from the UK Biobank can be accessed through the website: https://www.ukbiobank.ac.uk/ Data from other sources are available through the NCBI's database of Genotypes and Phenotypes (dbGaP) and the European Genomic Archive (EGA): https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000280.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000287.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000893.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000336.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v32.p13 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000753.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000788.v2.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000674.v3.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000209.v13.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000634.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000147.v3.p1 https://ega-archive.org/datasets/EGAD00010000264I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll results produced in the present study are contained in the manuscript. All data sets used in this study are publicly available to researchers by creating an account for the relevant data sources and following posted instructions for obtaining access. Primary data from Women's Health Initiative used for this analysis are available through dbGap and the WHI website: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000746.v3.p3 https://www.whi.org Phenotypic WHI data alone are available through BioLINCC: https://biolincc.nhlbi.nih.gov/home/ Data from the UK Biobank can be accessed through the website: https://www.ukbiobank.ac.uk/ Data from other sources are available through the NCBI's database of Genotypes and Phenotypes (dbGaP) and the European Genomic Archive (EGA): https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000280.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000287.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000893.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000336.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v32.p13 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000753.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000788.v2.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000674.v3.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000209.v13.p3 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000634.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000147.v3.p1 https://ega-archive.org/datasets/EGAD00010000264 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000746.v3.p3 https://www.whi.org https://biolincc.nhlbi.nih.gov/home/ https://www.ukbiobank.ac.uk/ https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000280.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000287.v7.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000893.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000336.v1.p1 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v32.p13 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000753.v1.p1